300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Andorra
Guernsey
Cameroon
Colombia
China
Sudan
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
South Africa
Moldova
Seychelles
Botswana
Paraguay
Canada
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
United States
Ireland
India
Germany
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Bolivia
Belize
Faroe Islands
Jersey
Algeria
Bahrain
Bahamas
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Liechtenstein
Cambodia
Lebanon
Mongolia
Peru
San Marino
Slovenia
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science Startup Investors in China (September 2026)

The most active venture capital funds and angel investors investing in China Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in China Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Prox Ventures
VC Fund
8 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $2.5M–$28M
Qiming Venture Partners
VC Fund
7 China, United States, Hong Kong Series B, Series A, Series C Health Care, Biotechnology, Medical $4.4M–$120M
HSG
VC Fund
6 China, United States, Australia Series B, Series A, Seed Artificial Intelligence, Biotechnology, Software $2M–$226M
Linear Capital
VC Fund
6 China, Singapore, Switzerland Seed, Angel, Series A Artificial Intelligence, Software, Manufacturing $1.4M–$122M
Lenovo Capital and Incubator Group (LCIG)
VC Fund
5 China, Hong Kong, United States Series A, Seed, Series B Manufacturing, Artificial Intelligence, Software $1.4M–$150M
Hillhouse Investment
VC Fund
5 China, United States, Singapore Series B, Series A, Series C Biotechnology, Health Care, Software $2.9M–$230M
Huagai Capital
VC Fund
4 China, United States, Hong Kong Series A, Series B, Angel Health Care, Biotechnology, Medical $425k–$90M
Hillhouse Ventures
VC Fund
4 China, Singapore, Norway Series A, Series B, Seed Manufacturing, Biotechnology, Health Care $10M–$120M
Vinno Capital
VC Fund
4 China, United States Series A, Series B, Seed Manufacturing, Semiconductor, Medical $1.4M–$139M
EFung Capital
VC Fund
4 China, United States, India Series B, Series A, Series C Health Care, Biotechnology, Medical $1.4M–$100M
Matrix Partners China
VC Fund
4 China, United States, Singapore Series A, Series B, Seed Health Care, Software, Biotechnology $1.6M–$137M
Dalton Venture
VC Fund
4 China, India, Canada Seed, Series A, Series B Health Care, Medical, Biotechnology $512k–$50M
Baidu Ventures
VC Fund
4 China, United States, Singapore Series A, Seed, Series B Artificial Intelligence, Health Care, Biotechnology $1.5M–$123M
Cenova
VC Fund
3 China, United States, Hong Kong Series B, Series A, Series C Medical, Health Care, Biotechnology $2.8M–$100M
Xinghua Dingli
VC Fund
3 China Seed, Series A, Series B Biotechnology, Medical, Biopharma $1.4M–$14M
Shenzhen Capital Group
VC Fund
3 China, United States, Japan Series A, Series B, Series C Manufacturing, Health Care, Software $1.5M–$156M
WuXi AppTec
VC Fund
3 United States, China, Israel Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $6M–$187M
Tianjin Venture Capital
VC Fund
3 China, United States Venture - Series Unknown, Seed Manufacturing, Information Technology, Biotechnology $462k–$41M
Entrepreneurship Relay Group
VC Fund
3 China Series A, Angel, Venture - Series Unknown Manufacturing, Software, Enterprise $222k–$30M
Legend Capital
VC Fund
3 China, United States, South Korea Series B, Series A, Series C Health Care, Medical, Biotechnology $1.6M–$200M
Haitang Fund
VC Fund
3 China Seed, Series A, Venture - Series Unknown Manufacturing, Biotechnology, Medical $1.5M–$103M
Jiadao Capital
VC Fund
3 China Seed, Angel, Series A Biotechnology, Manufacturing, Medical $1.4M–$49M
Longpan Investment
VC Fund
3 China, United States, Cayman Islands Series A, Seed, Series B Health Care, Medical, Biotechnology $14M–$60M
CITIC Capital Holdings
VC Fund
3 China, United States, Japan Series A, Series B, Series C Manufacturing, Health Care, Biotechnology $3.2M–$230M
MiraclePlus
VC Fund
3 China, United States, Singapore Seed, Angel, Pre-Seed Artificial Intelligence, Software, Information Technology
CD Capital
VC Fund
3 China, United States Series A, Series B, Seed Health Care, Biotechnology, Medical Device $1.4M–$34M
Northern Light Venture Capital
VC Fund
3 China, United States, South Korea Series A, Series B, Seed Health Care, Medical, Biotechnology $1.3M–$60M
Shunxi Fund
VC Fund
3 China Series A, Seed, Series B Biotechnology, Manufacturing, Medical $1.5M–$86M
ZSVC
VC Fund
3 China, United States, India Series A, Seed, Series B Manufacturing, Medical, Health Care $1.4M–$84M
ULTIMA
VC Fund
3 China Angel, Series A, Series B Health Care, Biotechnology, Fitness $462k–$15M
Inspiration Capital
VC Fund
3 China Seed, Series A, Series B Manufacturing, Artificial Intelligence, Sensor $1.5M–$16M
Oriental Fortune Capital
VC Fund
3 China, United States Series A, Series B, Seed Software, Manufacturing, Information Technology $1.4M–$100M
BioVenture
VC Fund
3 China, United States, Hong Kong Series A, Series B, Seed Health Care, Biotechnology, Medical $4.4M–$73M
Orient Securities Capital Investment
VC Fund
2 China Series A, Series B, Venture - Series Unknown Manufacturing, Health Care, Software $1.4M–$684M
Tsinghua Capital
VC Fund
2 China, Australia Seed, Angel, Series A Manufacturing, Artificial Intelligence, Biotechnology $425k–$73M
Lucion
VC Fund
2 China Series A, Series B Biotechnology, Manufacturing, Medical $1.4M–$539M
Innoangel Fund
VC Fund
2 China, Canada, Hong Kong Angel, Seed, Series A Artificial Intelligence, Robotics, Manufacturing $425k–$27M
Shangshi Fund
VC Fund
2 China Series A, Angel, Seed Information Technology, Manufacturing, Artificial Intelligence $283k–$73M
Gaw Capital Partners
VC Fund
2 China, Singapore, United States Series A, Seed, Series C Real Estate, Hotel, Internet $3M–$250M
Frees Fund
VC Fund
2 China, United States, Singapore Series A, Seed, Angel Artificial Intelligence, Health Care, Biotechnology $425k–$35M
Vivo Capital
VC Fund
2 United States, China, United Kingdom Post-IPO Equity, Series B, Series C Biotechnology, Health Care, Pharmaceutical $28M–$180M
Ascendis Pharma
VC Fund
2 China Series A, Series B Life Science, Biotechnology, Pharmaceutical $40M–$40M
ASBV
VC Fund
2 China, Australia, Hong Kong Seed, Series A, Angel Health Care, Medical, Biotechnology $425k–$34M
Green Pine Capital Partners
VC Fund
2 China, United States, Canada Series A, Angel, Series B Artificial Intelligence, Biotechnology, Software $425k–$150M
BOHE Angel Fund
VC Fund
2 China Angel, Seed, Series A Health Care, Medical, Biotechnology $1.4M–$100M
Jinqiu Fund
VC Fund
2 China, United States, Hong Kong Seed, Series A, Angel Artificial Intelligence, Robotics, Manufacturing
Med-Fine Capital
VC Fund
2 China, Hong Kong, United States Series A, Seed, Series B Medical, Health Care, Biotechnology $3M–$60M
Highlight Capital
VC Fund
2 China, United States, South Korea Series A, Series B, Seed Health Care, Medical, Biotechnology $3M–$84M
Puhua Capital
VC Fund
2 China, United Kingdom, United States Series A, Series B, Seed Health Care, Medical, Manufacturing $1.5M–$103M
Shunwei Capital
VC Fund
2 China, United States, India Series A, Series B, Series C Manufacturing, Software, Internet $1.5M–$105M
Access all 673 investors in China Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 8 investments in China Life Science startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 82
  • Round size: Seed $2.5M–$14M; Series A $3M–$28M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Shengxin Medical — Shengxin Medical is a cardiovascular interventional medical device developer, dedicated to creating innovative, high-quality solutions that improve the diagnosis, treatment, and management of cardiovascular diseases, while advancing minimally invasive medical technologies to enhance patient outcomes and clinical efficiency.
  • Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
  • Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Show all investments...

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 7 investments in China Life Science startups

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 1112
  • Round size: Series A $4.4M–$50M; Series B $8.5M–$88M; Series C $12M–$120M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely actively investing — fresh fund, raised $8M in 2026

Portfolio highlights

  • Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
  • Guangjing Energy — Guangjing Energy specializes in the R&D and mass production of durable, large-area perovskite solar cell modules. They develops perovskite film printing technology with independent intellectual property rights and realized the preparation of large-area perovskite components.
  • Shennapsi Artificial Intelligence Technology — Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterolmonitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.
Show all investments...

HSG
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 6 investments in China Life Science startups

HSG is a leading venture capital and private equity firm investing globally in the technology, healthcare, and consumer sectors.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Software
  • Stage:Series B, Series A, Seed
  • Geography: China, United States, Australia

Investor stats

  • Total investments: 970
  • Round size: Seed $2M–$50M; Series A $4.4M–$100M; Series B $12M–$226M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $2.5B in 2024

Portfolio highlights

  • Z.ai — The AI Lab behind GLM models, dedicated to inspiring the development of AGI to benefit humanity. https://t.co/gOw7WpwkJt https://t.co/ot9sGVXU8x
  • Hypershell — An exoskeleton innovator reshaping lifestyles and enabling technology to empower life.
  • Suisheng Technology — Suisheng Technology is an innovative company specializing in AI-driven memory services, dedicated to developing intelligent solutions that help individuals and businesses capture, organize, and retrieve important information with greater efficiency and precision.
Show all investments...

Linear Capital
VC Fund · Shanghai, Shanghai, China · 6 investments in China Life Science startups, 24 in the past 12 months

Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Manufacturing
  • Stage:Seed, Angel, Series A
  • Geography: China, Singapore, Switzerland

Investor stats

  • Total investments: 93
  • Round size: Seed $1.4M–$122M; Angel $1.4M–$122M; Series A $5.7M–$29M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $300M in 2022

Portfolio highlights

  • Zhengqi Future — Zhengqi Future focuses on developing embody intelligent robots for a 3km radius living environment.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
  • Unbounded Dynamics — Unbounded Dynamics is a robotics and embodied intelligence startup focused on developing foundational AI “brains” and operational intelligence for robots and autonomous systems aimed at industrial and B-end scenarios. It works on the coordination of perception (“eyes”), manipulation (“hands”), and decision-making (“brain”) in physical robots bybuilding general basic models and expert system integrations as part of a hardware-software architecture to enable continuous iterative evolution of embodied intelligence.
Show all investments...

Lenovo Capital and Incubator Group (LCIG)
VC Fund · Beijing, Beijing, China · 5 investments in China Life Science startups

Lenovo Capital and Incubator Group is an accelerator and venture capital firm.

Show more...

Investment focus

  • Industry: Manufacturing, Artificial Intelligence, Software
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 342
  • Round size: Seed $1.4M–$42M; Series A $1.5M–$74M; Series B $8M–$150M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $500M in 2016

Portfolio highlights

  • Violoop — Violoop is a Chinese AI hardware startup Specializes in AI-PC automation hardware as a "physical-level AI Operator", bridging legacy software and AI agents for 24/7 workflows without APIs.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
  • SenseTime Medical — SenseTime Medical promotes the development and implementation of its medical big model and provides smart health solutions.
Show all investments...

Hillhouse Investment
VC Fund · Changyang, Beijing, China · 5 investments in China Life Science startups

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 331
  • Round size: Series A $2.9M–$157M; Series B $15M–$230M; Series C $15M–$220M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — raised $11B in 2018

Portfolio highlights

  • Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
  • Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
  • NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Show all investments...

Huagai Capital
VC Fund · Beijing, Beijing, China · 4 investments in China Life Science startups, 9 in the past 12 months

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 150
  • Round size: Angel $425k–$15M; Series A $1.4M–$73M; Series B $3.5M–$90M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $430M in 2018

Portfolio highlights

  • SeaArt — SeaArt AI is an all-in-one AI creativity community for art, videos, audio, and AI chats, where creators collaborate, spark inspiration, and grow together.
  • GigaAI — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
  • Falcon Technology — Falcon Technology focuses on DSA processor design innovation, developing a dedicated computing technology ecosystem based on the RISC-V architecture to deliver high-performance, energy-efficient processing solutions for next-generation intelligent computing applications.
Show all investments...

Hillhouse Ventures
VC Fund · Singapore, Central Region, Singapore · 4 investments in China Life Science startups

Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: China, Singapore, Norway

Investor stats

  • Total investments: 77
  • Round size: Seed $10M–$120M; Series A $10M–$85M; Series B $14M–$99M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Yatsen Holding — Yasten provides high-quality fashion makeup products.
  • kaye technology — Kaye Technology is a company that provides automation upgrade solutions for beverage equipment.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Show all investments...

Vinno Capital
VC Fund · Shenzhen, Guangdong, China · 4 investments in China Life Science startups

Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.

Show more...

Investment focus

  • Industry: Manufacturing, Semiconductor, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 39
  • Round size: Series A $1.4M–$70M; Series B $11M–$139M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • MatriQ
  • Ruimeng Semiconductor — Ruimeng Semiconductor is a provider of intelligent human-machine interface processor chips and solutions.
  • Baisheng Smart Computing — Baisheng Smart Computing specializes in the field of information technology application innovation, operations, and maintenance.
Show all investments...

EFung Capital
VC Fund · Shenzhen, Guangdong, China · 4 investments in China Life Science startups

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 84
  • Round size: Series A $1.4M–$36M; Series B $14M–$100M; Series C $14M–$74M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Xinyun Life — Xinyun Life Sciences is a high tech medical enterprise focusing on the R&D and industrialization of artificial intelligence vascular intervention devices. The company integrates AI deeply into its hardware development using a unique dual closed- oop system.
  • Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
  • Heluo New Image — Heluo New Image is a cell treatment platform developer that focuses on iPSC directed differentiation, gene editing, large-scale cell product production, and cell therapy technology development.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Matrix Partners China
VC Fund · Beijing, Beijing, China · 4 investments in China Life Science startups

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 622
  • Round size: Seed $1.6M–$74M; Series A $2.9M–$61M; Series B $10M–$137M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely still investing — raised $92M in 2023

Portfolio highlights

  • Lexin — LexinFintech Holdings is an online consumer finance platform for educated young adults in China. As one of China's leading financial technology companies, Lexin integrates its e-commerce-driven installment finance platform, Fenqile, with advanced risk management technologies, the Company's Dingsheng online investment platform, and theCompany's Juzi Licai online investment platform for individual investors, to create a comprehensive consumer finance ecosystem. The Company utilizes technologies including big data, cloud computing and artificial intelligence to enable the near-instantaneous matching of user funding requests with offers from the Company's more than 30 funding partners, which include commercial banks, consumer finance companies, and other licensed financial institutions. By serving the credit needs of China's educated young adults, Lexin helps its more than 20 million registered users to enjoy a better quality of life through the use of better credit.
  • Camera360 — Camera360 is a professional but easy-to use App for photo editing and selfie retouching. Tag #camera360
  • Liepin — Liepin is the largest and most professional high-end talent community-based recruitment site, with its innovative products and unique service model model for create an interactive high-end talent recruitment platform between business, headhunting and workplace. Tens of thousands of professional executive search consultant for businesses and jobseekers set up communication between the bridge and accelerate corporate recruitment process, recommended paying jobs in the workplace, career development planning. 16 job seekers to avoid the risk of privacy protection, millions of high-end elite member libraries, help enterprises development needs.
Show all investments...

Dalton Venture
VC Fund · Shanghai, Shanghai, China · 4 investments in China Life Science startups

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: China, India, Canada

Investor stats

  • Total investments: 142
  • Round size: Seed $512k–$5M; Series A $2.9M–$17M; Series B $2.8M–$50M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • PowerMicro — PowerMicro focuses on the cutting-edge interdisciplinary field of “stem cells + engineered scaffolds,” specializing in the application of iPSC technology to advance regenerative medicine, tissue engineering, and innovative therapeutic solutions.
  • NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
  • Active Technology — Active Technology is a pioneering deep tech startup specialized in developing invasive brain computer interface (BCI) technology. The company integrates flexible electrodes, dedicated chips, and advanced decoding algorithms to target motor, visual, and emotional neural pathways.
Show all investments...

Baidu Ventures
VC Fund · Beijing, Beijing, China · 4 investments in China Life Science startups

Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 241
  • Round size: Seed $1.9M–$28M; Series A $1.5M–$43M; Series B $8M–$123M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: Likely still investing — raised $141M in 2023

Portfolio highlights

  • Sondit — Sondit specializes in R&D and manufacturing of civilian radar systems. It includes intelligent transportation, intelligent security, vehicle-road coordination, and other fields. It engaged in traffic information monitoring and urban traffic management in the field of the intelligent transportation industry.
  • Stellar Power — Stellar Power is an aerospace energy technology company focused on the research and development of advanced space energy technologies, specializing in innovative hard-tech solutions for energy generation, storage, and transmission to support the future of aerospace and space exploration industries.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Show all investments...

Cenova
VC Fund · Shanghai, Shanghai, China · 3 investments in China Life Science startups, 9 in the past 12 months

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 60
  • Round size: Series A $2.8M–$45M; Series B $13M–$61M; Series C $15M–$100M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Simnova — Simnova Biotherapeutics is a biopharmaceutical company that focuses on the research and development of cell therapies for cancer treatment. The company's primary therapeutic focus is CAR-based cell therapy for patients with either hematologic malignancies or solid tumors. Simnova Biotherapeutics is known for its innovative approach todeveloping patient-centered therapeutics using current science and technology. The company's lead product is SNC102, a cell therapy product that has been approved for clinical trials. Simnova Biotherapeutics is committed to creating a healthy, inclusive, and harmonious working environment.
  • Deep Cell — Deep Cell is a Chinese AI driven drug discovery and virtual cell modeling startup. The company integrates artificial intelligence with multi scale molecular physics to construct explainable virtual cell world models, aiming to revolutionize paradigm shifting drug designs and simulate cellular responses to complex diseases.
  • Accro Bioscience — Accro Bioscience research centers on the molecular mechanism of regulated cell death such as necroptosis, pyroptosis, and ferroptosis.
Show all investments...

Xinghua Dingli
VC Fund · 3 investments in China Life Science startups

Xinghua Dingli is an investment company.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Biopharma
  • Stage:Seed, Series A, Series B
  • Geography: China

Investor stats

  • Total investments: 13
  • Round size: Seed $1.4M–$14M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Puyuan Bio — Puyuan Bio engages in the clinical quantitative detection of tumor-specific mRNA in human peripheral blood. Its technology can provide an important clinical diagnosis basis for the presence of hematogenous spread of tumor cells and dynamic monitoring of the disease.The company has a talented team with doctoral tutors, doctors, and masters as themain body, and has 9 national invention patents in related fields. The company was approved by the Ministry of Science and Technology of Science and Technology Small and Medium Enterprises Technology Innovation Fund and passed the acceptance inspection. It is an enterprise settled in the technology transfer plan of Anhui Province and has been included in the Hefei Shuangqian Project. It was supported by the Development and Reform Commission in 2018.The registration application materials of the cytokeratin 19 (CK19) mRNA nucleic acid detection kit (PCR-fluorescent probe method) have been accepted by the State Food and Drug Administration, the on-site inspection of the medical device production quality management standard has been passed, and the approval number will be obtained soon. When it is put into production, it will contribute to public health.
  • Kaiwang Data — Kaiwang Data is a one-stop shop for data solutions. It focuses on offering complete data labeling solutions for automakers and businesses involved in autonomous driving.
  • Gaowei Medicine — Gaowei Medicine is a drug discovery platform for developing new drugs for key intractable diseases such as cancer and neurological diseases.
Show all investments...

Shenzhen Capital Group
VC Fund · Shenzhen, Guangdong, China · 3 investments in China Life Science startups

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 601
  • Round size: Series A $1.5M–$128M; Series B $13M–$141M; Series C $4.4M–$156M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Prosemi — Pusenmei is a precision micro-resistance current sensor developer company committed to delivering professional and diverse precision micro-resistance current detecting resistors and circuit protection solutions.
  • Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
  • Waker Biology — Weike Bio is a gene therapy drug development company.
Show all investments...

WuXi AppTec
VC Fund · Shanghai, Shanghai, China · 3 investments in China Life Science startups

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 49
  • Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$187M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2015

Portfolio highlights

  • D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
  • Structure Therapeutics — Medicine is our platform. Accessibility is our cure.
Show all investments...

Tianjin Venture Capital
VC Fund · Tianjin, Guangdong, China · 3 investments in China Life Science startups

Tianjin Venture Capital is an investment firm.

Show more...

Investment focus

  • Industry: Manufacturing, Information Technology, Biotechnology
  • Stage:Venture - Series Unknown, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 108
  • Round size: Seed $462k–$15M; Venture - Series Unknown $4.4M–$41M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
  • Xingneng Xuanguang — Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology.
  • Innovec Biotherapeutics — Innovec Biotherapeutics Specialized in gene therapy technology and medication development.
Show all investments...

Entrepreneurship Relay Group
VC Fund · Yangpu, Hainan, China · 3 investments in China Life Science startups

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Enterprise
  • Stage:Series A, Angel, Venture - Series Unknown
  • Geography: China

Investor stats

  • Total investments: 24
  • Round size: Series A $222k–$30M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Songying Technology — Songying Technology focuses on the research and development of cloud-native real-time 3D engines and graphics collaboration platforms.
  • Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
  • Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Show all investments...

Legend Capital
VC Fund · Beijing, Beijing, China · 3 investments in China Life Science startups

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 481
  • Round size: Series A $1.6M–$93M; Series B $11M–$107M; Series C $15M–$200M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $177M in 2021

Portfolio highlights

  • Z.ai — The AI Lab behind GLM models, dedicated to inspiring the development of AGI to benefit humanity. https://t.co/gOw7WpwkJt https://t.co/ot9sGVXU8x
  • Huixin Bio — Huixin Bio is a developer of exosome purification products and early cancer detection technology.
  • Shunyuan Technology — Shunyuan Technology is a high-tech enterprise specializing in the development of fusion simulators and advanced route design solutions, providing innovative technologies and intelligent systems for complex engineering, transportation, and industrial applications.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Haitang Fund
VC Fund · Nankai, Tianjin, China · 3 investments in China Life Science startups, 17 in the past 12 months

Haitang Fund is a venture capital fund jointly established by Tianjin University alumni entrepreneurs and other alumni and entrepreneurs.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Medical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: China

Investor stats

  • Total investments: 51
  • Round size: Seed $7.9M–$15M; Series A $1.5M–$103M; Venture - Series Unknown $14M–$44M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • MemoraX AI — MemoraX AI is an innovator in the field of tailored memory for huge models.
  • Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
  • Xingkan Jiuzhou — Xingkan Jiuzhou is a technology-based enterprise specializing in radio signal reception, demodulation, analysis, and transmitter location.
Show all investments...

Jiadao Capital
VC Fund · 3 investments in China Life Science startups, 11 in the past 12 months

Jiadao Capital is an investment Firm.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Medical
  • Stage:Seed, Angel, Series A
  • Geography: China

Investor stats

  • Total investments: 24
  • Round size: Seed $2.2M–$15M; Angel $1.4M–$49M; Series A $15M–$15M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Garen Semiconductor — Garen Semiconductor focuses on the R&D, production and sales of semiconductor materials (such as gallium oxide).
  • Yongquan Innovation — Yongquan Innovation is a technological firm that specializes in sophisticated desktop CNC machinery.
  • Active Technology — Active Technology is a pioneering deep tech startup specialized in developing invasive brain computer interface (BCI) technology. The company integrates flexible electrodes, dedicated chips, and advanced decoding algorithms to target motor, visual, and emotional neural pathways.
Show all investments...

Longpan Investment
VC Fund · Beijing, Beijing, China · 3 investments in China Life Science startups, 14 in the past 12 months

Longpan Investment is an investment firm.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Cayman Islands

Investor stats

  • Total investments: 44
  • Round size: Seed $14M–$60M; Series A $14M–$32M; Series B $14M–$37M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Jingling Zhikang — Jingling Zhikang is technology company specializing in the intersection of medical rehabilitation, robotics, and embodied artificial intelligence. The company focuses on developing intelligent rehabilitation bionic hands and upper-limb prosthetics.
  • Hanyue New Materials — Hanyue Advanced Materials is a high-tech company that specializes in single-use biopharmaceutical solutions.
  • Lingtai Krypton Biotechnology — Lingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.
Show all investments...

CITIC Capital Holdings
VC Fund · Central, Hong Kong Island, Hong Kong · 3 investments in China Life Science startups

CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 104
  • Round size: Series A $3.2M–$230M; Series B $7.2M–$50M; Series C $10M–$220M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $2.8B in 2018

Portfolio highlights

  • Genta Kyushu Bio — Genta Kyushu Bio is a cutting edge biotechnology company specializing in the development of precision neuro circuit therapies for central nervous system and ophthalmic diseases. The firm leverages its high throughput screening and drug development platforms to advance innovative treatments utilizing chemogenetics, optogenetics, and gene therapies.
  • Healthy Tree — Healthy Tree is a comprehensive solution provider for self-medication devices.
  • Neolix — Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc.
Show all investments...

MiraclePlus
VC Fund · Haidian, Beijing, China · 3 investments in China Life Science startups, 15 in the past 12 months

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Angel, Pre-Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 76
  • Lead/follow: no public data

Portfolio highlights

  • TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
  • Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
  • Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
Show all investments...

CD Capital
VC Fund · Shanghai, Shanghai, China · 3 investments in China Life Science startups

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 73
  • Round size: Seed $1.4M–$15M; Series A $1.5M–$32M; Series B $7.6M–$34M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Genlight — Genlight develops innovative treatment solutions for epilepsy and other neurological diseases. Genlight is headquartered in Hangzhou, China.
  • Pipi Bear — Pipi Bear is a creator of living robots and health goods, with a focus on those that improve the lives of the elderly.
  • CORE Biomedicine — CORE Biomedicine is a private, preclinical-stage biotechnology company that specializes in drug discovery and development for oncology.
Show all investments...

Northern Light Venture Capital
VC Fund · Beijing, Beijing, China · 3 investments in China Life Science startups

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 360
  • Round size: Seed $1.3M–$60M; Series A $2.9M–$40M; Series B $10M–$58M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
  • Moge Microflow — Moge Microflow is a manufacturer of equipment for microreactors. It provides continuous flow production technologies and equipment for nanomaterials, pharmaceutical intermediates, and fine chemicals, as well as standardized high-end microreactor equipment.
  • Bianzhong New Materials — Bianzhong New Materials is a high-tech company that specializes in the research and development of equipment for weaving and shaping three-dimensional preforms of high-strength fiber composite materials.
Show all investments...

Shunxi Fund
VC Fund · Beijing, Beijing, China · 3 investments in China Life Science startups

Shunxi Fund is an investment Fund. It is managed by Beijing State-owned Capital Operations and Management.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Medical
  • Stage:Series A, Seed, Series B
  • Geography: China

Investor stats

  • Total investments: 74
  • Round size: Seed $2.4M–$20M; Series A $1.5M–$78M; Series B $14M–$86M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Deep Cell — Deep Cell is a Chinese AI driven drug discovery and virtual cell modeling startup. The company integrates artificial intelligence with multi scale molecular physics to construct explainable virtual cell world models, aiming to revolutionize paradigm shifting drug designs and simulate cellular responses to complex diseases.
  • Aerospace Era — Aerospace Era engages in the research and development of aerospace propulsion and high-speed aircraft.
  • Sunmiao Technology — Sunmiao Technology focused on the research and development of 3D computing chips.
Show all investments...

ZSVC
VC Fund · Beijing, Beijing, China · 3 investments in China Life Science startups, 16 in the past 12 months

ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, India

Investor stats

  • Total investments: 144
  • Round size: Seed $1.4M–$4M; Series A $1.5M–$21M; Series B $2.8M–$84M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Tpson — Tpson is a Smart Hardware company.
  • Ounuo Semiconductor — Ounuo Semiconductor is a manufacturing company that provides research and development of semiconductor equipment.
  • HUAXI Technology — HUAXI Technology is a global leader specializing in the development and delivery of comprehensive, high-end smart elderly care solutions. By integrating advanced technologies such as the Internet of Things (IoT), artificial intelligence (AI), and big data analytics, the company is dedicated to enhancing the quality of life for seniors worldwide.
Show all investments...

ULTIMA
VC Fund · Chengdu, Sichuan, China · 3 investments in China Life Science startups

ULTIMA is an investment management firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Fitness
  • Stage:Angel, Series A, Series B
  • Geography: China

Investor stats

  • Total investments: 7
  • Round size: Angel $462k–$1.4M; Series A $1.5M–$15M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
  • HC Scientific — HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Inspiration Capital
VC Fund · 3 investments in China Life Science startups, 8 in the past 12 months

Inspiration Capital is an investment firm.

Show more...

Investment focus

  • Industry: Manufacturing, Artificial Intelligence, Sensor
  • Stage:Seed, Series A, Series B
  • Geography: China

Investor stats

  • Total investments: 23
  • Round size: Seed $1.5M–$15M; Series A $16M–$16M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • Youshu Quantum — Youshu Quantum is a deep-tech startup specializing in quantum computing software, middleware, and proprietary algorithms.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
  • Chipworld Optoelectronics — Shanghai Xinjie Guanghe Technology Co., Ltd. is a high-tech chip design enterprise specializing in the research, development, and engineering of all-optical interconnect platforms and silicon-based optical switching chips for artificial intelligence computing clusters.
Show all investments...

Oriental Fortune Capital
VC Fund · Shenzhen, Guangdong, China · 3 investments in China Life Science startups

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 306
  • Round size: Seed $1.5M–$100M; Series A $1.4M–$30M; Series B $3.2M–$100M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • CellWall — Cellwall is a desktop robot developer focused on the research, development, upgrade, and marketing of its initial product, CyboPal ONE.
  • Lightwheel — Light Wheel Intelligence is offers automated, physically precise and controllable, real and generalizable synthetic data solutions to build AI data infrastructure,
  • Chengdu Zhongweida Xinko Technology — Chengdu Zhongweida Xinko Technology is an IT firm that specializes in quantum computing and control technology products.
Show all investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 3 investments in China Life Science startups

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 189
  • Round size: Seed $7.9M–$41M; Series A $4.4M–$47M; Series B $7.1M–$73M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $204M in 2016

Portfolio highlights

  • SiranBio — SiranBio is a biotechnology that develops innovative siRNA drugs.
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Show all investments...

Orient Securities Capital Investment
VC Fund · Shanghai, Shanghai, China · 2 investments in China Life Science startups, 7 in the past 12 months

Orient Securities Capital Investment is an private equity fund business platform.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Software
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: China

Investor stats

  • Total investments: 42
  • Round size: Series A $1.4M–$73M; Series B $1.4M–$100M; Venture - Series Unknown $7.5M–$684M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • AutoAgents — AutoAgents is committed to offering software services for intelligent assistants (Copilot) and autonomous agents (AI Agents) through AI.
  • Linkcharging Technology — LINCHR specializes in the research and development of energy vehicle charging equipment, on-board charging, new energy microgrid, and intelligent detection, providing one-stop solutions for new energy vehicle applications.
  • Greenwich Optoelectronic — Sichuan Greenwich Optics Technology Co., Ltd. manufactures ultra-precision optical components and intelligent polishing equipment utilizing proprietary robotic platforms and simulation algorithms. The company provides nano-level surface processing solutions for hardware used in the semiconductor, aerospace, and laser industries.
Show all investments...

Tsinghua Capital
VC Fund · Haidian, Beijing, China · 2 investments in China Life Science startups

Tsinghua Capital is an investment firm.

Show more...

Investment focus

  • Industry: Manufacturing, Artificial Intelligence, Biotechnology
  • Stage:Seed, Angel, Series A
  • Geography: China, Australia

Investor stats

  • Total investments: 74
  • Round size: Seed $1.4M–$73M; Angel $425k–$14M; Series A $2.3M–$17M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
  • Qinghao Puzhong — Qinghao Puzhong is a technological development and manufacturing company that produces resin-infiltrated ceramic-based dental restoration materials.
  • Zhiyuan Shenlan — Zhiyuan Shenlan focuses on data-driven biomolecule design and manufacturing.
Show all investments...

Lucion
VC Fund · Jinan, Shandong, China · 2 investments in China Life Science startups, 9 in the past 12 months

Lucion is an influential professional venture capital institute.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Medical
  • Stage:Series A, Series B
  • Geography: China

Investor stats

  • Total investments: 56
  • Round size: Series A $1.4M–$539M; Series B $2.8M–$144M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Robot Era — Robot era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products. Xingdong Era is committed to the development of universal humanoid robots that can adapt to a wide range of fields, multiple scenarios, and high intelligence, striving to realize the beautiful vision of intelligent robotsentering thousands of households and integrating into the lights of thousands of homes.
  • Oricell Therapeutics — OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.
  • Wutong Sensing Control — Wutong Sensing Control is a leading company that specializes in the research, development, and innovation of cutting-edge robotic mechanics and tactile sensing technologies. With a strong focus on advancing automation systems, the company aims to enhance the precision, efficiency, and adaptability of robotic applications in various industries,including manufacturing, healthcare, and consumer electronics.
Show all investments...

Innoangel Fund
VC Fund · Beijing, Beijing, China · 2 investments in China Life Science startups

Innoangel Fund is an investment firm that invests in early stage companies.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Robotics, Manufacturing
  • Stage:Angel, Seed, Series A
  • Geography: China, Canada, Hong Kong

Investor stats

  • Total investments: 216
  • Round size: Seed $425k–$27M; Angel $425k–$14M; Series A $1.4M–$14M
  • Lead/follow: 30% lead, 70% follow

Portfolio highlights

  • InfinAstro — InfinAstro is a firm that develops and manufactures rocket engines, rocket launch equipment, rocket control systems, and microsatellites.
  • Zhidao Hechuang — Zhidao Hechuang is a comprehensive solution provider for new energy asset management.
  • Zhiyuan Shenlan — Zhiyuan Shenlan focuses on data-driven biomolecule design and manufacturing.
Show all investments...

Shangshi Fund
VC Fund · Beijing, Beijing, China · 2 investments in China Life Science startups, 14 in the past 12 months

Shangshi Fund is an investment firm.

Show more...

Investment focus

  • Industry: Information Technology, Manufacturing, Artificial Intelligence
  • Stage:Series A, Angel, Seed
  • Geography: China

Investor stats

  • Total investments: 62
  • Round size: Seed $1.4M–$73M; Angel $283k–$2.1M; Series A $1.4M–$71M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Approaching.AI — Approaching.AI is an AI Infra company focusing on the important large model application scenarios such as RAG.
  • Qianjue Technology — Qianjue Technology is a company that created the first full-stack application-level robot model and offers cloud-based artificial intelligence solutions to robot manufacturers.
  • Optical Interconnect Technology
Show all investments...

Gaw Capital Partners
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in China Life Science startups

Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.

Show more...

Investment focus

  • Industry: Real Estate, Hotel, Internet
  • Stage:Series A, Seed, Series C
  • Geography: China, Singapore, United States

Investor stats

  • Total investments: 22
  • Round size: Seed $3M–$11M; Series A $4.8M–$25M; Series C $11M–$250M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: May invest from a new fund soon — raised $430M in 2021

Portfolio highlights

  • Blackpanda — Asia's premier digital forensics and cyber incident response firm.
  • SARELLY SARELLY — SARELLY SARELLY is a gender-neutral and transparent fashion brand, offering affordable luxury to the Hispanic Gen Z community.
  • NPX Point Avenue — NPX Point Avenue is an education technology company focused on the fast-growing K-12 private international school market and K-12 after-school training market.
Show all investments...

Frees Fund
VC Fund · Beijing, Beijing, China · 2 investments in China Life Science startups

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Biotechnology
  • Stage:Series A, Seed, Angel
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 211
  • Round size: Seed $1.4M–$14M; Angel $425k–$17M; Series A $1.4M–$35M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $130M in 2015

Portfolio highlights

  • SoundAI — Sound Technology is a science and technology innovation company that specializes in acoustics frontier technology and artificial intelligence interaction. It is committed to lead the more interactive experience of artificial intelligence in the real environment and realize the human-computer interaction vision that "listen to you and know whatyou think".
  • Methuselah — Methuselah is a research and development manufacturer of medical nutritional food.
  • Chuguang 3D — Chuguang 3D is a optical micro-nano 3D sensor technology platform that focuses on research and development, and manufacturing of micro-nano-level optical three-dimensional sensing and measurement and testing instruments.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Vivo Capital
VC Fund · Palo Alto, California, United States · 2 investments in China Life Science startups

The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists,entrepreneurs, operating executives, and industry experts. The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Post-IPO Equity, Series B, Series C
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 260
  • Round size: Series B $28M–$137M; Series C $30M–$142M; Post-IPO Equity $35M–$180M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely actively investing — fresh fund, raised $740M in 2025

Portfolio highlights

  • Entera Bio — Entera Bio is developing novel oral drugs by utilizing its proprietary cutting edge delivery technology This technology protects large molecules and peptides in the GI tract. Oral drug delivery is the most straight forward and user friendly approach to medical treatment. Entera Bio has key personnel with the relevant know how, experience andnetworks working together to enable rapid development of its products. The company has an experienced management team with more than 50 years of combined drug development experience.
  • Expedition Therapeutics — Redefining Care. Advancing COPD and Other Respiratory Therapies. Expedition Therapeutics is developing novel treatments for inflammatory and respiratory diseases with the potential to fundamentally transform patient care worldwide. ABOUT US At Expedition Therapeutics, we believe that disease-controlling treatments that address fundamental disease mechanisms should be the new standard for chronic obstructive pulmonary disease (COPD). Our
  • BlossomHill Therapeutics — We are on a mission to exponentially improve the number of quality years for patients.
Show all investments...

Ascendis Pharma
VC Fund · Palo Alto, California, United States · 2 investments in China Life Science startups

We apply our TransCon technology platform to build a leading, fully integrated biopharma company & make a meaningful difference for patients, caregivers & HCPs.

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Pharmaceutical
  • Stage:Series A, Series B
  • Geography: China

Investor stats

  • Total investments: 3
  • Round size: Series A $40M–$40M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Visen Pharmaceuticals — Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs that address significant unmet needs for patients in Greater China.
Show all investments...

ASBV
VC Fund · Shenzhen, Guangdong, China · 2 investments in China Life Science startups

ASBV focuses on early and mid-term venture capital investments.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: China, Australia, Hong Kong

Investor stats

  • Total investments: 28
  • Round size: Seed $3M–$14M; Angel $425k–$425k; Series A $1.4M–$34M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
  • Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
  • Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Show all investments...

Green Pine Capital Partners
VC Fund · Shenzhen, Guangdong, China · 2 investments in China Life Science startups

Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Software
  • Stage:Series A, Angel, Series B
  • Geography: China, United States, Canada

Investor stats

  • Total investments: 228
  • Round size: Angel $425k–$2.9M; Series A $1.4M–$94M; Series B $3M–$150M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $42M in 2025

Portfolio highlights

  • Enrikenuo — Enrikenuo is a biotechnology company that focuses on the research and development of new generation CAR-NK technology based cell drugs.
  • IO-AI Tech — IO-AI Tech develops specialized data infrastructure to connect physical robots, AI models, and real-world training environments. The company's core value proposition relies on its end-to-end hardware and software products—such as teleoperation tools and motion capture units—which allow developer teams to capture, visualize, and managehigh-precision multimodal data. By automating complex data pipelines and annotations, the business model scales the collection of high-quality training assets essential for deploying frontier physical intelligence.
  • Sungen Biomedical — Sungen Biomedical is an innovative antibody drug R&D enterprise. It has established international standard technology platforms and original biological macromolecular R&D pipelines. Their focus includes therapeutic drugs for cardiovascular and cerebrovascular diseases, tumors, and more.
Show all investments...

BOHE Angel Fund
VC Fund · Suzhou, Jiangsu, China · 2 investments in China Life Science startups

BOHE Angel Fund is an investment Fund.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Angel, Seed, Series A
  • Geography: China

Investor stats

  • Total investments: 16
  • Round size: Seed $14M–$15M; Angel $1.4M–$100M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • KangaBio — KangaBio is a biotech business specializing in developing novel medicines to meet unmet medical needs. It helps in developing prodrugs of immune-stimulating medicines and other multi-specific biologics to minimize toxicities and boost treatment efficacy for already established targets.
  • PrinoPharma — PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
  • Qinhao Pharmaceutical — Qinhao Pharmaceutical is harmaceutical enterprises with a gathering of humanities and innovation.
Show all investments...

Jinqiu Fund
VC Fund · Beijing, Beijing, China · 2 investments in China Life Science startups

Jinqiu Fund invests in biotechnology companies

Show more...

Investment focus

  • Industry: Artificial Intelligence, Robotics, Manufacturing
  • Stage:Seed, Series A, Angel
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 35
  • Lead/follow: no public data

Portfolio highlights

  • MindOn — MindOn is a robotics company that develops artificial intelligence software and algorithms to create humanoid robots.
  • Miracle Rabbi — MiracleRabi is an AI-powered trendsetting brand focused on the research, development, and promotion of AI toys, integrating cutting-edge artificial intelligence, interactive technologies, and imaginative design to create engaging, educational, and emotionally intelligent play experiences that inspire creativity and redefine the future of smartentertainment.
  • Qingxian Intelligence — Qingxian Intelligence is a smart office and home office technology company. The company focuses on smart, comfortable, and healthy office scenarios.
Show all investments...

Med-Fine Capital
VC Fund · Shanghai, Shanghai, China · 2 investments in China Life Science startups

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 83
  • Round size: Seed $8M–$60M; Series A $3M–$40M; Series B $12M–$60M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $73M in 2019

Portfolio highlights

  • Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
  • Tianyikang Biotechnology — Tianyikang Biotechnology focuses on medical research and the development and application of next-generation cell immunotherapy products.
  • Beijing Ansong Technology — Beijing Ansong Technology Co., Ltd. is an enterprise focusing on the research and development, production, and sales of orthopedic medical devices. The company cooperates with domestic and foreign universities, research institutes, and doctors in hospitals, and is committed to creating original orthopedic products with independent knowledgeproducts.Beijing Ansong Technology was founded on June 27, 2011 by Liang Tao in Fengtai, Beijing.
Show all investments...

Highlight Capital
VC Fund · Nanjin, Jiangsu, China · 2 investments in China Life Science startups, 32 in the past 12 months

Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 177
  • Round size: Seed $10M–$84M; Series A $3M–$73M; Series B $7.6M–$70M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $563M in 2021

Portfolio highlights

  • Genuine Rhythm — Genuine Rhythm is an innovative AI Agent technology developer specializing in bespoke agent creation, advanced algorithm R&D, and rigorous security compliance solutions tailored to diverse enterprise needs.
  • PoShell Robotics — PoShell Robotics is a general-purpose home robot, aiming to create a home-friendly and structurally stable robot.
  • Xunlu Innovation — Xunlu Innovation is a cutting-edge bicycle manufacturer based in Shenzhen, China, specializing in intelligent electric cargo bikes designed to meet modern urban mobility needs.
Show all investments...

Puhua Capital
VC Fund · Hangzhou, Zhejiang, China · 2 investments in China Life Science startups

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Show more...

Investment focus

  • Industry: Health Care, Medical, Manufacturing
  • Stage:Series A, Series B, Seed
  • Geography: China, United Kingdom, United States

Investor stats

  • Total investments: 272
  • Round size: Seed $2.3M–$29M; Series A $1.5M–$42M; Series B $3M–$103M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • Nuoyun Drive
  • Ganzhicao Technology — Gancao Doctor is an internet-based Traditional Chinese Medicine (TCM) company that helps clinics modernize their digital management and optimize operations. By using AI-assisted features, it enhances doctors' diagnostic and treatment abilities, delivering valuable benefits to doctors, patients, and clinics.
  • Interstellar Lightyear — Interstellar Lightyear Technology is a developer specializing in dexterous robotic hands, focusing on creating intelligent dexterous hands with advanced capabilities for precise manipulation.
Show all investments...

Shunwei Capital
VC Fund · Beijing, Beijing, China · 2 investments in China Life Science startups

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Internet
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 574
  • Round size: Series A $1.5M–$35M; Series B $8M–$55M; Series C $25M–$105M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $1.2B in 2018

Portfolio highlights

  • uban — Uban provides an internet office leasing and trading services platform that helps to connect owners, customers and brokers, corporate customers in order to provide office rental and follow-up services, enabling its clients to receive real estate related services through a single portal. The company is based in Beijing, China.
  • Z.ai — The AI Lab behind GLM models, dedicated to inspiring the development of AGI to benefit humanity. https://t.co/gOw7WpwkJt https://t.co/ot9sGVXU8x
  • Darma — DARMA - Digital Healt
Show all investments...

Life Science Investor funding in China at a glance

Stats across 368 deals from 673 investors.

673
investors
in China Life Science startups
368
deals
in China Life Science startups
$16M
median round
in China Life Science startups
36%
lead investors
lead at least one round
27%
Series A
most common funding stage
99/1
VC / Angel
share of investor count

Access all 673 investors in China Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in China investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 673 investors investing in China Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists